▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Inhibrx Biosciences (NASDAQ: INBX)

$14.38

(-2.0%)

-$0.30

Price as of June 12, 2025, 3:58 p.m. ET

Inhibrx Biosciences Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
INBX	-13.26%			+5%
S&P	+11.51%	+98.77%	+14.72%	+15%

Inhibrx Biosciences Company Info

Inhibrx Biosciences, Inc. operates as an American clinical-stage biotechnology company for biologic therapeutic candidates. The private company is based in DE.

News & Analysis

Featured Article

These Are Billionaires’ Favorite Healthcare Stocks

The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.

Jack Caporal | May 15, 2024

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services